Chen et al. found that in hepatocellular carcinoma, CIP2A inhibited PP2A activity, upregulated phospho-Akt and Akt signaling pathway, and inhibited cell apoptosis [19, 20]. Here, AKT1 is linked to hepatocellular carcinoma.